Ubiquitination Pathway Modulation

Ubiquitination pathway modulation targets protein tagging and degradation processes. Proteasome inhibitors accumulate ubiquitinated proteins causing apoptosis. E1 ubiquitin-activating enzyme inhibition prevents ubiquitination. Deubiquitinase inhibition prevents protein degradation. Selective ubiquitin ligase targeting improves specificity.

Cancer cell selectivity from replication dependency increases efficacy. Resistance mechanisms including compensatory pathway activation warrant investigation. Regulatory submissions justify mechanism targeting. Post-approval monitoring identifies resistance patterns. Emerging technologies improve pathway targeting.